Racura Oncology Ltd (ASX:RAC)
2.640
+0.050 (1.93%)
Apr 29, 2026, 4:10 PM AEST
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 473.22 million as of April 28, 2026. Its market cap has increased by 177.96% in one year.
Market Cap
473.22M
Enterprise Value
452.28M
Revenue
3.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.64
Market Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 473.22M, an increase of 3,644.70%. That is a compound annual growth rate of 44.74%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 455.87M |
| Opthea | 738.77M |
| Starpharma Holdings | 315.86M |
| Tetratherix | 240.12M |
| Orthocell | 236.04M |
| Dimerix | 234.15M |
| Clarity Pharmaceuticals | 1.16B |
| PYC Therapeutics | 1.29B |